The selectively released PM down-regulated the expression of PD-L1 protein by effectively inhibiting tumor mitochondria function, resulting in a significant increase of CD3+, CD4+, and CD8+ infiltration in the tumors. The gene discussed is CD4; the disease is neoplasm.